drugset / Trial / NCT02165566
Humalog or Humulin for Intensive Insulin Therapy in Intensive Care Unit
RandomizedCrossoverOpen-labelTreatment
Summary
Insulin preparation -random assignment to regular insulin lin or lispro insulin as first treatment- was administered at constant infusion rate (0.04 units/Kg/h) in patients presenting blood glucose concentration ≥180 mg/dl and was discontinued when blood glucose concentration ≤140 mg/dl (therapeutic blood glucose concentration drop). Further reduction in blood glucose concentration after discontinuation of insulin infusion was recorded (post-infusional blood glucose concentration drop). During the study period blood glucose concentration, in whole blood, was measured every 30 minutes. At least 6 hours interval was allowed between the 2 treatments.
Timeline
- Start
- 2013-03
- Primary completion
- 2014-03
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | 0.04 iu/kg | Other |
| Subject | Insulin Lispro | Protein / enzyme biologic | 0.04 iu/kg | Other |